Cite
HARVARD Citation
Liou, J. et al. (2016). Concomitant, bismuth quadruple, and 14-day triple therapy in the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial. Lancet. 388 (10058), pp. 2355-2365. [Online].